 CRANFORD, N.J., Sept. 14, 2021 PRNewswire -- Citius Pharmaceuticals, Inc. Citius or the Company Nasdaq: CTXR, a biopharmaceutical company dedicated to the development and commercialization of first-in-class critical care products with a focus on oncology, anti-infective products in adjunct cancer care, unique prescription products and stem cell therapies, today announced that it will be joining Benzingas All Access Show for a 20-minute interview on Friday, September 17, 2021 at 10:10 am ET. 